Sanofi Sues Mylan Over Prostate Drug — Again
Weeks after it sued Mylan Pharmaceuticals Inc. and a slew of other generics in a Delaware district court over the patents for prostate treatment Uroxatral, Sanofi-Aventis filed another such complaint against...To view the full article, register now.
Already a subscriber? Click here to view full article